Legal & General Group’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-288
| Closed | -$16.9K | – | 3454 |
|
|
2024
Q1 | $16.9K | Hold |
288
| – | – | ﹤0.01% | 3032 |
|
|
2023
Q4 | $6.39K | Hold |
288
| – | – | ﹤0.01% | 3300 |
|
|
2023
Q3 | $6.22K | Sell |
288
-2,909
| -91% | -$114K | ﹤0.01% | 3345 |
|
|
2023
Q2 | $216K | Sell |
3,197
-128
| -4% | -$52.9K | ﹤0.01% | 2723 |
|
|
2023
Q1 | $1.55M | Buy |
3,325
+209
| +7% | +$111K | ﹤0.01% | 1990 |
|
|
2022
Q4 | $1.25M | Buy |
3,116
+103
| +3% | +$39.5K | ﹤0.01% | 2079 |
|
|
2022
Q3 | $980K | Buy |
3,013
+57
| +2% | +$18.4K | ﹤0.01% | 2152 |
|
|
2022
Q2 | $781K | Sell |
2,956
-68
| -2% | -$17.4K | ﹤0.01% | 2238 |
|
|
2022
Q1 | $909K | Buy |
3,024
+30
| +1% | +$10.5K | ﹤0.01% | 2256 |
|
|
2021
Q4 | $1.05M | Buy |
2,994
+14
| +0.5% | +$4.36K | ﹤0.01% | 2223 |
|
|
2021
Q3 | $761K | Buy |
2,980
+642
| +27% | +$227K | ﹤0.01% | 2312 |
|
|
2021
Q2 | $1.56M | Buy |
2,338
+90
| +4% | +$51.9K | ﹤0.01% | 2077 |
|
|
2021
Q1 | $1.95M | Buy |
2,248
+20
| +0.9% | +$21.3K | ﹤0.01% | 1992 |
|
|
2020
Q4 | $2.07M | Buy |
2,228
+320
| +17% | +$336K | ﹤0.01% | 1876 |
|
|
2020
Q3 | $1.96M | Sell |
1,908
-139
| -7% | -$150K | ﹤0.01% | 1770 |
|
|
2020
Q2 | $2.08M | Buy |
2,047
+187
| +10% | +$174K | ﹤0.01% | 1723 |
|
|
2020
Q1 | $1.62M | Sell |
1,860
-120
| -6% | -$119K | ﹤0.01% | 1668 |
|
|
2019
Q4 | $2.12M | Buy |
1,980
+298
| +18% | +$304K | ﹤0.01% | 1770 |
|
|
2019
Q3 | $1.55M | Buy |
1,682
+172
| +11% | +$189K | ﹤0.01% | 1823 |
|
|
2019
Q2 | $1.71M | Sell |
1,510
-118
| -7% | -$129K | ﹤0.01% | 1765 |
|
|
2019
Q1 | $2.21M | Buy |
1,628
+386
| +31% | +$523K | ﹤0.01% | 1664 |
|
|
2018
Q4 | $1.44M | Buy |
1,242
+174
| +16% | +$196K | ﹤0.01% | 1739 |
|
|
2018
Q3 | $1.62M | Hold |
1,068
| – | – | ﹤0.01% | 1780 |
|
|
2018
Q2 | $1.67M | Sell |
1,068
-35
| -3% | -$45.6K | ﹤0.01% | 1742 |
|
|
2018
Q1 | $1.27M | Sell |
1,103
-86
| -7% | -$113K | ﹤0.01% | 1808 |
|
|
2017
Q4 | $1.42M | Buy |
1,189
+70
| +6% | +$87.8K | ﹤0.01% | 1757 |
|
|
2017
Q3 | $1.5M | Buy |
1,119
+266
| +31% | +$280K | ﹤0.01% | 1705 |
|
|
2017
Q2 | $684K | Buy |
853
+92
| +12% | +$64.1K | ﹤0.01% | 1960 |
|
|
2017
Q1 | $469K | Sell |
761
-8
| -1% | -$4.87K | ﹤0.01% | 2048 |
|
|
2016
Q4 | $414K | Buy |
769
+228
| +42% | +$114K | ﹤0.01% | 2028 |
|
|
2016
Q3 | $278K | Buy |
541
+99
| +22% | +$46.6K | ﹤0.01% | 1947 |
|
|
2016
Q2 | $181K | Hold |
442
| – | – | ﹤0.01% | 1813 |
|
|
2016
Q1 | $235K | Sell |
442
-14
| -3% | -$6.98K | ﹤0.01% | 1678 |
|
|
2015
Q4 | $350K | Buy |
456
+75
| +20% | +$49.8K | ﹤0.01% | 1478 |
|
|
2015
Q3 | $210K | Buy |
381
+69
| +22% | +$41.8K | ﹤0.01% | 1673 |
|
|
2015
Q2 | $183K | Buy |
312
+253
| +429% | +$147K | ﹤0.01% | 1790 |
|
|
2015
Q1 | $47K | Buy |
+59
| New | +$45.7K | ﹤0.01% | 2521 |
|
Other funds holding KYNB
AC
6CM
GCP
Legal & General Group's KYNB Position: Q2 2024 in Review
Legal & General Group sold out of Kyntra Bio (KYNB) in Q2 2024, closing a stake of 288 shares — an estimated $16.9K sold.
Legal & General Group first reported a position in KYNB in Q1 2015 and held it in 37 quarters. The position peaked at $2.21M in Q1 2019. 102 funds tracked by Wall St. Rank hold KYNB as of Q2 2024.
- Legal & General Group reported no remaining Kyntra Bio position as of Q2 2024 after selling out during the quarter.
- Legal & General Group sold 288 Kyntra Bio shares in Q2 2024, an estimated $16.9K.
- Legal & General Group first reported a position in Kyntra Bio in Q1 2015 and held it in 37 quarters.
- Legal & General Group's Kyntra Bio position peaked at $2.21M in Q1 2019.
- 102 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2024.
Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.